In January, Johnson & Johnson CEO Alex Gorsky said the company was considering whether to sell its blood diagnostics division in Raritan, where it employs about 800 people.

We conduct scientific & medical literature evaluations for clients of the biopharmaceutical industry within the scope of our expertise. Target or technology pipeline and corporate benchmark analysis ...